151 related articles for article (PubMed ID: 22329401)
1. Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex.
Pagano S; Satta N; Werling D; Offord V; de Moerloose P; Charbonney E; Hochstrasser D; Roux-Lombard P; Vuilleumier N
J Intern Med; 2012 Oct; 272(4):344-57. PubMed ID: 22329401
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage.
Pruijm M; Schmidtko J; Aho A; Pagano S; Roux-Lombard P; Teta D; Burnier M; Vuilleumier N
Ther Apher Dial; 2012 Dec; 16(6):588-94. PubMed ID: 23190520
[TBL] [Abstract][Full Text] [Related]
3. CD14 as a Mediator of the Mineralocorticoid Receptor-Dependent Anti-apolipoprotein A-1 IgG Chronotropic Effect on Cardiomyocytes.
Mannic T; Satta N; Pagano S; Python M; Virzi J; Montecucco F; Frias MA; James RW; Maturana AD; Rossier MF; Vuilleumier N
Endocrinology; 2015 Dec; 156(12):4707-19. PubMed ID: 26393305
[TBL] [Abstract][Full Text] [Related]
4. Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability.
Montecucco F; Vuilleumier N; Pagano S; Lenglet S; Bertolotto M; Braunersreuther V; Pelli G; Kovari E; Pane B; Spinella G; Pende A; Palombo D; Dallegri F; Mach F; Roux-Lombard P
Eur Heart J; 2011 Feb; 32(4):412-21. PubMed ID: 21224292
[TBL] [Abstract][Full Text] [Related]
5. Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4.
Montecucco F; Braunersreuther V; Burger F; Lenglet S; Pelli G; Carbone F; Fraga-Silva R; Stergiopulos N; Monaco C; Mueller C; Pagano S; Dallegri F; Mach F; Vuilleumier N
Thromb Haemost; 2015 Aug; 114(2):410-22. PubMed ID: 25879306
[TBL] [Abstract][Full Text] [Related]
6. Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.
Vuilleumier N; Rossier MF; Pagano S; Python M; Charbonney E; Nkoulou R; James R; Reber G; Mach F; Roux-Lombard P
Eur Heart J; 2010 Apr; 31(7):815-23. PubMed ID: 20176799
[TBL] [Abstract][Full Text] [Related]
7. Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis.
Pagano S; Carbone F; Burger F; Roth A; Bertolotto M; Pane B; Spinella G; Palombo D; Pende A; Dallegri F; Satta N; Virzi J; Fontana P; Mach F; Montecucco F; Vuilleumier N
Thromb Haemost; 2016 Aug; 116(3):554-64. PubMed ID: 27356567
[TBL] [Abstract][Full Text] [Related]
8. Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis.
Vuilleumier N; Bas S; Pagano S; Montecucco F; Guerne PA; Finckh A; Lovis C; Mach F; Hochstrasser D; Roux-Lombard P; Gabay C
Arthritis Rheum; 2010 Sep; 62(9):2640-50. PubMed ID: 20506304
[TBL] [Abstract][Full Text] [Related]
9. Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis.
Wick PA; Mombelli A; Pagano S; Moren X; Giannopoulou C; Mach F; Roux-Lombard P; Vuilleumier N
J Periodontal Res; 2013 Jun; 48(3):350-6. PubMed ID: 23050768
[TBL] [Abstract][Full Text] [Related]
10. Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes.
Carbone F; Satta N; Montecucco F; Virzi J; Burger F; Roth A; Roversi G; Tamborino C; Casetta I; Seraceni S; Trentini A; Padroni M; Dallegri F; Lalive PH; Mach F; Fainardi E; Vuilleumier N
Eur J Clin Invest; 2016 Sep; 46(9):805-17. PubMed ID: 27490973
[TBL] [Abstract][Full Text] [Related]
11. Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis.
Mirlashari MR; Lyberg T
Med Sci Monit; 2003 Aug; 9(8):BR316-24. PubMed ID: 12942028
[TBL] [Abstract][Full Text] [Related]
12. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction.
Keller PF; Pagano S; Roux-Lombard P; Sigaud P; Rutschmann OT; Mach F; Hochstrasser D; Vuilleumier N
J Intern Med; 2012 May; 271(5):451-62. PubMed ID: 22061093
[TBL] [Abstract][Full Text] [Related]
14. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1.
Pagano S; Yerly S; Meyer B; Juillard C; Suh N; Le Terrier C; Daguer JP; Farrera-Soler L; Barluenga S; Piumatti G; Hartley O; Lemaitre B; Eberhardt CS; Siegrist CA; Eckerle I; Stringhini S; Guessous I; Kaiser L; Pugin J; Winssinger N; Vuilleumier N
Eur J Clin Invest; 2021 Nov; 51(11):e13661. PubMed ID: 34324704
[TBL] [Abstract][Full Text] [Related]
17. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.
Ellingsen E; Morath S; Flo T; Schromm A; Hartung T; Thiemermann C; Espevik T; Golenbock D; Foster D; Solberg R; Aasen A; Wang J
Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760
[TBL] [Abstract][Full Text] [Related]
18. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
Arslan F; Smeets MB; O'Neill LA; Keogh B; McGuirk P; Timmers L; Tersteeg C; Hoefer IE; Doevendans PA; Pasterkamp G; de Kleijn DP
Circulation; 2010 Jan; 121(1):80-90. PubMed ID: 20026776
[TBL] [Abstract][Full Text] [Related]
19. Identification of soluble CD14 as an endogenous agonist for Toll-like receptor 2 on human astrocytes by genome-scale functional screening of glial cell derived proteins.
Bsibsi M; Bajramovic JJ; Van Duijvenvoorden E; Persoon C; Ravid R; Van Noort JM; Vogt MH
Glia; 2007 Apr; 55(5):473-82. PubMed ID: 17205552
[TBL] [Abstract][Full Text] [Related]
20. Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens.
Raby AC; Holst B; Le Bouder E; Diaz C; Ferran E; Conraux L; Guillemot JC; Coles B; Kift-Morgan A; Colmont CS; Szakmany T; Ferrara P; Hall JE; Topley N; Labéta MO
Sci Transl Med; 2013 May; 5(185):185ra64. PubMed ID: 23677593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
